Cargando…
Functional Precision Oncology: The Next Frontier to Improve Glioblastoma Outcome?
Glioblastoma remains the most malignant and intrinsically resistant brain tumour in adults. Despite intensive research over the past few decades, through which numerous potentially druggable targets have been identified, virtually all clinical trials of the past 20 years have failed to improve the o...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369403/ https://www.ncbi.nlm.nih.gov/pubmed/35955765 http://dx.doi.org/10.3390/ijms23158637 |